DNA repair gene XPD polymorphism and lung cancer risk: a meta-analysis

Lung Cancer ◽  
2004 ◽  
Vol 46 (1) ◽  
pp. 1-10 ◽  
Author(s):  
Z. Hu ◽  
Q. Wei ◽  
X. Wang ◽  
H. Shen
2015 ◽  
Vol 102 (4) ◽  
pp. 332-339 ◽  
Author(s):  
Liu Bei ◽  
Tan Xiao-dong ◽  
Gao Yu-fang ◽  
Sun Jian-ping ◽  
Ying Zhao-yu

Tumor Biology ◽  
2013 ◽  
Vol 34 (5) ◽  
pp. 2521-2527 ◽  
Author(s):  
Gang Ding ◽  
Weiguo Xu ◽  
Hongwei Hua ◽  
Qian Huang ◽  
Hongxiang Liang ◽  
...  

2015 ◽  
Author(s):  
Qingyi Wei ◽  
Hongliang Liu ◽  
Zhensheng Liu ◽  
Christopher I. Amos ◽  
Jennifer A. Doherty ◽  
...  

2010 ◽  
Vol 2010 ◽  
pp. 1-17 ◽  
Author(s):  
Chikako Kiyohara ◽  
Koichi Takayama ◽  
Yoichi Nakanishi

Genetic variations in DNA repair genes are thought to modulate DNA repair capacity and are suggested to be related to lung cancer risk. We conducted a meta-analysis of epidemiologic studies on the association between genetic polymorphisms in both base excision repair and nucleotide excision repair pathways, and lung cancer. We found xeroderma pigmentosum complementation group A (XPA) G23A (odds ratio (OR)=0.76, 95% confidence interval (CI)=0.61–0.94), 8-oxoguanine DNA glycosylase 1 (OGG1) Ser326Cys (OR=1.22, 95% CI=1.02–1.45), and excision repair cross-complementing group 2 (ERCC2) Lys751Gln (OR=1.27, 95% CI=1.10–1.46) polymorphisms were associated with lung cancer risk. Considering the data available, it can be conjectured that if there is any risk association between a single SNP and lung cancer, the risk fluctuation will probably be minimal. Advances in the identification of new polymorphisms and in high-throughput genotyping techniques will facilitate the analysis of multiple genes in multiple DNA repair pathways. Therefore, it is likely that the defining feature of future epidemiologic studies will be the simultaneous analysis of large samples of cases and controls.


Sign in / Sign up

Export Citation Format

Share Document